Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Studies have revealed a robust and independent correlation between chronic kidney disease (CKD) and cardiovascular (CV) events, including death, heart failure, and myocardial infarction. Recent clinical trials extend this range of adverse CV events, including malignant ventricular arrhythmias and su...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Márcio Galindo Kiuchi, Jan K. Ho, Janis Marc Nolde, Leslie Marisol Lugo Gavidia, Revathy Carnagarin, Vance B. Matthews, Markus P. Schlaich
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2020-01-01
coleção:	Frontiers in Physiology
Assuntos:	chronic kidney disease sympathetic nervous system hypertension left ventricular hypertrophy sudden cardiac death ventricular remodeling
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fphys.2019.01546/full

Registros relacionados

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Janis M. Nolde, et al.
Publicado em: (2021-08-01)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
por: Revathy Carnagarin, et al.
Publicado em: (2019-01-01)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
por: Márcio Kiuchi, et al.
Publicado em: (2019-12-01)

The effect of bilateral cardiac sympathetic denervation for refractory ventricular tachycardia in ischemic cardiomyopathy
por: Yuko Miki, et al.
Publicado em: (2020-06-01)

Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
por: Márcio G. Kiuchi, et al.
Publicado em: (2016-03-01)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Lakshini Y. Herat, et al.
Publicado em: (2018-01-01)

Microvascular changes at different stages of chronic kidney disease
por: Dennis Kannenkeril, et al.
Publicado em: (2021-02-01)

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation
por: Veronica Dusi, et al.
Publicado em: (2021-01-01)

Device-based approaches for renal nerve ablation for hypertension and beyond
por: Alicia Ann Thorp, et al.
Publicado em: (2015-07-01)

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
por: Leslie Marisol Lugo‐Gavidia, et al.
Publicado em: (2022-06-01)

Sudden Cardiac Death and Idiopathic Ventricular Arrhythmias
por: Vries Lennart de, et al.
Publicado em: (2015-12-01)

Transgenic models of cardiac arrhythmias and sudden death
por: Carol Ann eRemme
Publicado em: (2013-03-01)

The Schlager mouse as a model of altered retinal phenotype
por: Lakshini Y Herat, et al.
Publicado em: (2020-01-01)

Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy
por: Shin-Huei Liu, et al.
Publicado em: (2021-12-01)

Efficacy and safety of cardiac sympathetic denervation for refractory ventricular arrhythmias: Experience of a Colombian hospital
por: Nicolas Arredondo-Mora, et al.
Publicado em: (2024-03-01)

Cardiac Sympathetic Denervation in Channelopathies
por: Veronica Dusi, et al.
Publicado em: (2019-03-01)

Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand?
por: Konstantinos C. Zekios, et al.
Publicado em: (2021-05-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
por: P.C. Brum, et al.
Publicado em: (2011-09-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
por: P.C. Brum, et al.
Publicado em: (2011-09-01)

Effects of Renal Denervation on Sympathetic Activation, Blood Pressure and Glucose Metabolism in Patients with Resistant Hypertension
por: Markus Peter Schlaich, et al.
Publicado em: (2012-02-01)

Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
por: Philipp Sasse, et al.
Publicado em: (2019-06-01)

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
por: D. S. Lebedev, et al.
Publicado em: (2021-08-01)

Case Report: The unrelenting journey—successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation
por: Hei-To Leung, et al.
Publicado em: (2024-12-01)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Janis M. Nolde, et al.
Publicado em: (2021-01-01)

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmia in Continuous-Flow Left Ventricular Assist Device
por: Peter P. Vlismas, MD, et al.
Publicado em: (2021-03-01)

Comments on 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Ali Deniz, et al.
Publicado em: (2016-02-01)

Editorial: The role of sex in cardiac arrhythmias and sudden cardiac death
por: Matias E. Pollevick, et al.
Publicado em: (2023-03-01)

Renal sympathetic denervation assisted treatment of electrical storm due to polymorphic ventricular tachycardia in a patient with cathecolaminergic polymorphic ventricular tachycardia
por: Tolga Aksu, et al.
Publicado em: (2017-07-01)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
por: Alicia A. Thorp, et al.
Publicado em: (2015-01-01)

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan
por: Masayoshi Mori, et al.
Publicado em: (2024-08-01)

Acute hemodynamics of cardiac sympathetic denervation
por: Kunal Sinkar, et al.
Publicado em: (2020-11-01)

Central sympathetic activation and arrhythmogenesis during acute myocardial infarction: modulating effects of endothelin-B receptors
por: Theofilos M Kolettis, et al.
Publicado em: (2015-02-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
por: Brian P. Betensky, et al.
Publicado em: (2014-01-01)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
por: Revathy Carnagarin, et al.
Publicado em: (2021-07-01)

Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58%
por: Toshihiko Goto, et al.
Publicado em: (2022-06-01)

Alcohol Ablation for Cardiac Arrhythmias: Is it Time to Drown the Arrhythmias?
por: Anandaraja Subramanian, MD, DM, FCE
Publicado em: (2012-07-01)

QUANTIFICATION OF ELECTROCARDIOGRAM RHYTHMICITY TO DETECT LIFE THREATENING CARDIAC ARRHYTHMIAS USING SPECTRAL ENTROPY
por: CHANDRAKAR KAMATH
Publicado em: (2013-10-01)

RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN EARLY REPOLARIZATION SYNDROME
por: Shpak N. V., et al.
Publicado em: (2019-11-01)

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
por: Jia Liao, et al.
Publicado em: (2024-02-01)

Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome
por: Elisabeth Annie Lambert, et al.
Publicado em: (2011-08-01)